Filtros de búsqueda

Lista de obras de Nicola Currò

A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.

artículo científico publicado en 2013

B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid Diseases

artículo científico publicado en 2015

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

artículo científico publicado en 2008

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

scientific article published on 04 October 2012

Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.

artículo científico publicado en 2014

Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis

scientific article published on 30 June 2009

Leishmaniasis of the eyelid mimicking an infundibular cyst and review of the literature on ocular leishmaniasis.

scientific article published on 06 December 2009

New immunomodulators in the treatment of Graves' ophthalmopathy

scientific article published on 15 April 2008

Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures

artículo científico publicado en 2008

PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.

artículo científico publicado en 2015

Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates

artículo científico publicado en 2009

Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.

artículo científico publicado en 2010

Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.

artículo científico publicado en 2012

Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.

artículo científico publicado en 2015

The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.

artículo científico publicado en 2013

Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy

artículo científico publicado en 2014

Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study

artículo científico publicado en 2007